S7 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

Subjects:

S2 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

Subjects:

Relative intensities of differential metabolites that may serve as potential metabolic biomarkers in Omicron variant cases. by Feng Gao (3548)

Subjects:

S4 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

Subjects:

S6 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

Subjects:

S5 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

Subjects:

ROC curve analysis for the predictive power of biomarkers for distinguishing between patients with Omicron variant and healthy controls. by Feng Gao (3548)

Subjects:

Analysis of the correlation between pharyngeal microbiomics, metabolomics and clinical indicators between OC and HC. by Feng Gao (3548)

Subjects:

Kaplan–Meier cumulative survival curve for infants exposed and not exposed to HIV. by Samuel Sendagala (21417164)

Subjects:

Metabolome KEGG enrichment analysis of serum in Omicron variant cases and recovered cases. by Feng Gao (3548)

Subjects:

Mortality dataset used in analysis. by Samuel Sendagala (21417164)

Subjects:

Untargeted metabolomic profiling of sera from Omicron variant cases of the discovery cohort. by Feng Gao (3548)

Subjects:

S8 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

Subjects:

Median ± IQR <i>M. plutonius</i> bacterial load (CFU/bee) of newly emerged summer worker bees inoculated with 1 × 10⁷ CFU/bee <i>M. plutonius</i> 2019BC1 and/or treated... by Midhun Sebastian Jose (19336846)

Table 1_Dual variants of uncertain significance in a case of hyper-IgM syndrome: implications for diagnosis and management.docx by Nourhen Agrebi (14151222)

“…Background<p>Hyper-IgM syndrome (HIGM) is a genetic immunodeficiency characterized by elevated to normal IgM levels and decreased IgG, IgA, and IgE. The overlapping clinical presentations of different gene mutations complicate diagnosis and management.…”

Sequential infection does not alter relative proportions of white blood cells. by Yuhao Li (1559569)

CTL response following combination therapy with NDV. by Hedieh Zargaran (21410233)

Heterogeneity test for population structure. by Yunying Cai (20721812)

“…<div><p>Innovation and entrepreneurship vitality, as a key factors in the development of the digital economy, significantly affects both regional economic development and residents’ consumption capacity. …”

Endogeneity test for variable lags. by Yunying Cai (20721812)

“…<div><p>Innovation and entrepreneurship vitality, as a key factors in the development of the digital economy, significantly affects both regional economic development and residents’ consumption capacity. …”

PBMC T cell subsets vary between mock- and sequentially-infected mice. by Yuhao Li (1559569)